NEW YORK CITY, NY / ACCESS Newswire / July 6, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Lifecore Biomedical, Inc. ("Lifecore" or "the Company") (NASDAQ: LFCR). Investors who purchased Lifecore securities prior to October 7, 2020, and continue to hold to the present, are encouraged to […]

NEW YORK CITY, NY / ACCESS Newswire / July 6, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Globe Life Inc. ("Globe Life" or "the Company") (NYSE: GL). Investors who purchased Globe Life securities prior to May 8, 2019, and continue to hold to the present, are

NEW YORK CITY, NY / ACCESS Newswire / July 6, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Amylyx Pharmaceuticals, Inc. ("Amylyx" or "the Company") (NASDAQ:AMLX). Investors who purchased Amylyx securities prior to November 11, 2022, and continue to hold to the present, are encouraged to obtain

NEW YORK, NY / ACCESS Newswire / July 6, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Arconic Corporation ("Arconic" or "the Company") (NYSE:ARNC). Investors who purchased Arconic securities prior to April 19, 2022, and continue to hold to the present, are encouraged to obtain additional information

NEW YORK CITY, NY / ACCESS Newswire / July 6, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sable Offshore Corp. ("Sable" or "the Company") (NYSE:SOC). Investors who purchased Sable securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/SOC.

NEW YORK CITY, NY / ACCESS Newswire / July 6, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of CTO Realty Growth, Inc. ("CTO" or "the Company") (NYSE:CTO). Investors who purchased CTO securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site:

NEW YORK CITY, NY / ACCESS Newswire / July 6, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Capricor Therapeutics, Inc. ("Capricor" or "the Company") (NASDAQ:CAPR). Investors who purchased Capricor securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/CAPR.

NEW YORK CITY, NY / ACCESS Newswire / July 6, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of PACS Group, Inc. ("PACS Group" or "the Company") (NYSE:PACS). Investors who purchased PACS Group securities prior to April 11, 2024, and continue to hold to the present, are encouraged

NEW YORK, NY / ACCESS Newswire / July 6, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ModivCare, Inc. ("ModivCare" or "the Company") (NASDAQ:MODV). Investors who purchased ModivCare securities prior to November 3, 2022, and continue to hold to the present, are encouraged to obtain additional information

NEW YORK CITY, NY / ACCESS Newswire / July 6, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Integral Ad Science Holding Corp. ("IAS" or "the Company") (NASDAQ:IAS). Investors who purchased IAS securities prior to March 2, 2023, and continue to hold to the present, are encouraged